Tilray Brands (TLRY) Is Up 6.2% After Posting Surprise Profit and Beating Analyst Expectations

• Tilray Brands reported first-quarter fiscal 2026 results in the past week, posting US$209.5 million in sales and a net profit that reversed prior-year losses, exceeding analyst expectations and marking a turnaround in operational momentum.
• The company's financial surprise comes amid heightened regulatory focus on U.S. cannabis reform and growing optimism around cannabis rescheduling, creating renewed interest in the sector despite fresh volatility from a newly announced share offering.
• We'll explore how Tilray's unexpected quarterly profit and improving operational efficiency could affect its long-term investment narrative.

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Tilray Brands Investment Narrative Recap

To believe in Tilray Brands as a shareholder, you need confidence in the company's ability to leverage global cannabis regulation trends and diversify beyond its core Canadian market. The recent swing to a first-quarter profit is significant, but real momentum in the stock still depends largely on U.S. cannabis reforms, a catalyst that remains uncertain in timing and scope. Despite this positive earnings surprise, the key risk of ongoing dilution persists and is material, especially following the latest share offering. Tilray’s filing of a universal shelf registration stands out as the most relevant recent announcement, coming immediately after its quarterly results. This allows the company to raise capital by issuing new shares or debt, which, while supporting future expansion efforts, amplifies dilution concerns for existing investors in light of ongoing operational and profitability challenges. However, investors should also be aware that while profitability may be turning a corner, recent share sales could threaten value for...

Read the full narrative on Tilray Brands (it's free!)

Tilray Brands' outlook anticipates $940.4 million in revenue and $193.4 million in earnings by 2028. This scenario requires a 4.6% annual revenue growth rate and an earnings increase of about $2.2 billion from current earnings of -$2.2 billion.

Uncover how Tilray Brands' forecasts yield a $1.11 fair value, a 35% downside to its current price.

Exploring Other Perspectives

The Simply Wall St Community includes 18 retail investor fair value estimates for Tilray Brands, ranging from US$1.11 to US$8.04 per share. While optimism about global cannabis legalization fuels many bullish estimates, continued capital raises and share dilution remain a pressing issue that could weigh on performance going forward.

Explore 18 other fair value estimates on Tilray Brands - why the stock might be worth over 4x more than the current price!

Build Your Own Tilray Brands Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Tilray Brands research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Tilray Brands research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Tilray Brands' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 35 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com